🇧🇷 Tabrecta in Brazil

Tabrecta (CAPMATINIB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Tabrecta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Tabrecta approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Tabrecta in Brazil?

Novartis Pharm is the originator. The local marketing authorisation holder may differ — check the official source linked above.